Revlimid is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Celgene Corporation. The primary component is Lenalidomide.
Product ID | 59572-420_1f462eb0-4995-4b06-93ce-27e3fcbe32d5 |
NDC | 59572-420 |
Product Type | Human Prescription Drug |
Proprietary Name | Revlimid |
Generic Name | Lenalidomide |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2013-06-06 |
Marketing Category | NDA / NDA |
Application Number | NDA021880 |
Labeler Name | Celgene Corporation |
Substance Name | LENALIDOMIDE |
Active Ingredient Strength | 20 mg/1 |
Pharm Classes | Thalidomide Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-06-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021880 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-06-10 |
Marketing Category | NDA |
Application Number | NDA021880 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-06-10 |
Ingredient | Strength |
---|---|
LENALIDOMIDE | 20 mg/1 |
SPL SET ID: | 5fa97bf5-28a2-48f1-8955-f56012d296be |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59572-402 | Revlimid | Lenalidomide |
59572-405 | Revlimid | Lenalidomide |
59572-410 | Revlimid | Revlimid |
59572-425 | Revlimid | Revlimid |
59572-415 | Revlimid | Revlimid |
59572-420 | Revlimid | Revlimid |
0378-1936 | Lenalidomide | Lenalidomide |
0378-1937 | Lenalidomide | Lenalidomide |
0378-1940 | Lenalidomide | Lenalidomide |
0378-1941 | Lenalidomide | Lenalidomide |
0480-1242 | Lenalidomide | Lenalidomide |
0480-1243 | Lenalidomide | Lenalidomide |
0480-1244 | Lenalidomide | Lenalidomide |
0480-1246 | Lenalidomide | Lenalidomide |
43598-511 | Lenalidomide | Lenalidomide |
43598-512 | Lenalidomide | Lenalidomide |
43598-513 | Lenalidomide | Lenalidomide |
43598-514 | Lenalidomide | Lenalidomide |
43598-515 | Lenalidomide | Lenalidomide |
43598-516 | Lenalidomide | Lenalidomide |
47781-484 | LENALIDOMIDE | Lenalidomide |
47781-485 | LENALIDOMIDE | Lenalidomide |
47781-486 | LENALIDOMIDE | Lenalidomide |
47781-488 | LENALIDOMIDE | Lenalidomide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REVLIMID 78795942 3255216 Live/Registered |
Celgene Corporation 2006-01-20 |
REVLIMID 78290583 3074309 Live/Registered |
Celgene Corporation 2003-08-21 |
REVLIMID 78188450 2925808 Live/Registered |
Celgene Corporation 2002-11-25 |
REVLIMID 76631301 3169244 Live/Registered |
Celgene Corporation 2005-02-14 |